Virtu Financial’s Acer Therapeutics Inc Warrant ACERW Stock Holding History

Virtu Financial’s Portfolio ACERW Stock Details ACERW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-47,466	Closed	-$1K	–	3051
2017 Q4	$1K	Sell	47,466 -407,587	-90%	-$13.5K	﹤0.01%	2299
2017 Q3	$35K	Buy	+455,053	New	+$37.4K	﹤0.01%	2276

Other funds holding ACERW

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

RPGK

Retirement Planning Group (Kansas) Leawood, Kansas $3.23B AUM 15.3% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Virtu Financial's ACERW Position: Q1 2018 in Review

Virtu Financial sold out of Acer Therapeutics Inc Warrant (ACERW) in Q1 2018, closing a stake of 47,466 shares — an estimated $1K sold.

Virtu Financial first reported a position in ACERW in Q3 2017 and held it in 2 quarters. The position peaked at $35K in Q3 2017. 4 funds tracked by Wall St. Rank hold ACERW as of Q1 2018.

Virtu Financial reported no remaining Acer Therapeutics Inc Warrant position as of Q1 2018 after selling out during the quarter.
Virtu Financial sold 47,466 Acer Therapeutics Inc Warrant shares in Q1 2018, an estimated $1K.
Virtu Financial first reported a position in Acer Therapeutics Inc Warrant in Q3 2017 and held it in 2 quarters.
Virtu Financial's Acer Therapeutics Inc Warrant position peaked at $35K in Q3 2017.
4 funds tracked by Wall St. Rank held Acer Therapeutics Inc Warrant as of Q1 2018.

Based on Virtu Financial's 13F filing for Q1 2018, filed 14 May 2018.